CPRX SG&A Expense Growth
Catalyst Pharmaceuticals Inc · SG&A Expense Growth
CPRX SG&A Expense Growth
Latest reported9.01%period ending
CPRX FY SG&A Growth (YoY) (0.00% → 9.01%)
Latest values, visible window
High-resolution chart · PNG
CPRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 9.0081% | |
| 32.9295% | |
| 134.2297% | |
| 15.0258% | |
| 12.1942% | |
| 19.9371% | |
| 132.3072% | |
| 117.3479% | |
| -7.6592% | |
| -7.9882% | |
| 92.1698% | |
| 101.9814% | |
| -13.5332% | |
| -5.0638% | |
| 22.2909% | |
| 1.3042% | |
| -0.2542% | |
| 7.22% | |
| 6.4441% | |
| 432.5062% | |
| 118.1362% | |
| 0% | |
| 0% | |
| 0% |